DSN: What can your company do to help retail sell-through in terms of merchandising and marketing?
MS: Trividia Health has always set itself apart from other manufacturers in the space as we are the co-brand leaders in the United States, manufacturing most of the retail pharmacy brands (along with our own national brands) in the United States, providing not only the products, but the marketing and advertising support to drive not only pharmacist recommendations, but consumer awareness and demand.
In addition, our consumer education program, “Meet Lance,” creates consumer-friendly, easy-to-understand tips, educating the consumer on all aspects of living a healthier lifestyle with diabetes and the products that help them to do that. The program has expanded to include Lance’s Pets — Buddy Dog and Keto Kitty — with simple, friendly and instructive educational material to help pet owners feel more comfortable about blood glucose testing and caring for their pet with diabetes.
DSN: Have your products taken on more importance with consumers during the pandemic?
MS: The arrival of COVID-19 has certainly increased awareness that keeping one’s diabetes in control is imperative.
Education and awareness are key as the specific needs of the consumer with diabetes become critical, as they are an at-risk population, with additional complications possible due to COVID-19. Monitoring and management play huge roles in addressing and preventing any additional complications.
In addition, we are working with retailers to develop omnichannel programs and create new pathways for consumers to decide how and where to order and receive their products as shopping patterns adapt to this new environment.
DSN: Any new products coming down the line?
MS: Trividia Health continues to innovate and develop high-quality, lower-cost solutions for people with diabetes, including 1) new blood glucose meters and test strips to address the features sought by consumers as their needs continue to evolve; 2) connected health solutions to provide prescribers, pharmacists and consumers the insights and ease of use to tighten the continuum of care, and create opportunities to monitor patients’ data and intervene; and 3) additional improvements and innovations to products that help consumers with diabetes live a healthier lifestyle.